[Inhibitors of hematopoiesis: from physiology to therapy].
A balance of both stimulatory and inhibitory factors interfere with gross and precise hematopoiesis regulation. A number of inhibitory molecules may endeavour a physiological role (cytokines like TGF beta, TNF alpha, platelet factor 4 PF4, Interferons, MIP1 alpha or peptides like p-EEDCK, Ac-SDKP. Hemopoietic primitive stem cells are relatively spared from chemo- or radiotherapy toxicity when they stay in a quiescent G0 state. They suffer from repeated toxic treatments when they undergo cycling. Molecules like the AcSDKP (seraspenide) inhibit in a reversible way stem cell and progenitors cycling, affording them a significant degree of protection from chemotherapy (cytarabine, cyclophosphamide, 5FU, AZT) and ionizing radiation toxicity. A clinical phase Ib study suggests protective effects from cytarabine toxicity.
Carde
P
P
Service de Médecine C Chimiothérapie, Institut Gustave Roussy, Villejuif.
D000595:Amino Acid Sequence; D006131:Growth Inhibitors / Q000494:pharmacology / Q000502:physiology*; D006410:Hematopoiesis / Q000187:drug effects / Q000502:physiology*; D006801:Humans; D008969:Molecular Sequence Data
D006131:Growth Inhibitors
Inhibiteurs de l'hématopoïèse: de la physiologie à la thérapeutique.